Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Mary Anne Dellva, MS
JCP
Original Research
Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
May 25, 2016
Susan G. Ball
,
Margaret B. Ferguson
,
James M. Martinez
, et al
JCP
Original Research
Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation
February 9, 2010
Stephen R. Marder
,
Sebastian Sorsaburu
,
Eduardo Dunayevich
, et al
JCP
Original Research
Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder
August 15, 2007
Eduardo Dunayevich
,
Haya Ascher-Svanum
,
Fangyi Zhao
, et al
JCP
Original Research
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis
March 1, 2001
Jöerg Czekalla
,
Charles M. Beasley, Jr.
,
Mary Anne Dellva
, et al
JCP
Original Research
Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia
May 15, 1997
Pierre V. Tran
,
Mary Anne Dellva
,
Gary D. Tollefson
, et al
